Primaquine Dosing for Vivax Malaria
Standard Dosing Regimen
- The CDC and WHO recommend a high-standard dose of 30 mg base per day (0.5 mg/kg/day) for 14 days for G6PD-normal adults 2
- An alternative standard dose is 15 mg base daily (0.25 mg/kg/day) for 14 days, though this lower dose may be insufficient for Southeast Asian strains 1, 3, 4, 5
- For children, the recommended dose is 0.3 mg/kg/day for 14 days 3, 4, 5
Critical Pre-Treatment Requirement
- G6PD testing is mandatory before primaquine administration to prevent life-threatening hemolysis 1, 2
- Primaquine should never be given to patients with severe G6PD deficiency without appropriate dose modification 3, 4
Modified Dosing for G6PD Deficiency
- For mild to moderate G6PD deficiency (30-70% activity), 45 mg base once weekly for 8 weeks can be used as an alternative regimen 1
- This weekly dosing reduces the risk of hemolysis while maintaining anti-hypnozoite efficacy 1
Contraindications
- Absolute contraindications include pregnancy, breastfeeding women, infants less than 6 months old, and severe G6PD deficiency 1
- Among Asian populations with high rates of severe G6PD deficiency, primaquine should not be administered for longer than 5 days without G6PD testing 3, 4
Clinical Implementation
- Primaquine should be started concurrently with blood schizontocidal treatment (chloroquine or ACT) 1
- Co-administration with chloroquine boosts primaquine blood levels, enhancing efficacy 1
- Monitor for hemolysis signs: dark urine, jaundice, fatigue, particularly in the first week of treatment 2
- Clinical improvement should occur within 48 hours of starting treatment 2
- Follow-up blood smears confirm parasite clearance 2
Safety Profile
- Both the standard (0.25 mg/kg/day) and high-standard (0.5 mg/kg/day) 14-day regimens are well-tolerated in G6PD-normal individuals with comparable safety profiles 1
- A retrospective study showed an 80% risk reduction of relapse in patients prescribed primaquine for P. vivax malaria 1